Literature DB >> 10465060

Influence of arterial pulse and reflective waves on systolic blood pressure and cardiac function.

G M London1, A Guérin.   

Abstract

Hypertension is a cardiovascular risk factor classically attributed to a reduction in the calibre and/or number of small arteries and arterioles resulting in increased peripheral vascular resistance. The definition of blood pressure as a product of total peripheral resistance (TPR) and cardiac output, however, does not take into account the fluctuation of blood pressure and flow during the cardiac cycle, with systolic and diastolic blood pressure representing the extremes of pulse pressure fluctuations. Diastolic blood pressure is closer to mean blood pressure (and therefore to TPR) than systolic blood pressure, and as such has been used as a marker for the diagnosis of hypertension. However, this approach has no rational basis and was challenged by the Framingham Heart Study which demonstrated that systolic rather than diastolic blood pressure is a better risk marker for stroke and coronary artery disease in subjects aged 45 years and older. This view has subsequently been confirmed by several epidemiological and interventional studies. Systolic blood pressure is closely associated with pulse pressure and is determined by the pattern of left ventricular ejection, arterial stiffness and timing of arterial wave reflections, i.e. the geometrical and viscoelastic properties of large conduit arteries. In humans, with ageing and hypertension, the arteries stiffen as a result of progressive degeneration of the arterial media, increased collagen and calcium content, and dilation and hypertrophy of large arteries and the aorta. Thus, the increase in systolic blood pressure (as a result of arterial damage) increases the fatigue of arterial walls and accelerates arterial damage, producing a self-perpetuating cycle.

Entities:  

Mesh:

Year:  1999        PMID: 10465060

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  8 in total

1.  Increased arterial wave reflection may predispose syncopal attacks.

Authors:  C H Chen; H H Hu; Y P Lin; C M Chern; T L Hsu; P Y Ding
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

2.  Chronic kidney disease stages 3-5 and cardiovascular disease in the veterans affairs population.

Authors:  Debasish Banerjee; Gabriel Contreras; Isabel Jaraba; Decio Carvalho; Luis Ortega; Cristiane Carvalho; Candido Pezon; Stephen P Rosenthal; Norman De La Rosa; Nuripama Vemuri; Gautam Cherla; Nilay Nahar
Journal:  Int Urol Nephrol       Date:  2009-01-01       Impact factor: 2.370

3.  Sympathetic overactivity prevails over the vascular amplifier phenomena in a chronic kidney disease rat model of hypertension.

Authors:  Omar Z Ameer; Cara M Hildreth; Jacqueline K Phillips
Journal:  Physiol Rep       Date:  2014-11-20

4.  Cardiovascular dynamics of Canadian Indigenous peoples.

Authors:  Heather J A Foulds; Shannon S D Bredin; Darren E R Warburton
Journal:  Int J Circumpolar Health       Date:  2018-12       Impact factor: 1.228

5.  The Frequency-Dependent Aerobic Exercise Effects of Hypothalamic GABAergic Expression and Cardiovascular Functions in Aged Rats.

Authors:  Yan Li; Ziqi Zhao; Jiajia Cai; Boya Gu; Yuanyuan Lv; Li Zhao
Journal:  Front Aging Neurosci       Date:  2017-06-30       Impact factor: 5.750

6.  Advances in the cardiovascular assessment of patients with chronic kidney disease.

Authors:  Chris W McIntyre; Stephen G John; Helen J Jefferies
Journal:  NDT Plus       Date:  2008-09-08

7.  Segmental differences of cervical spinal cord motion: advancing from confounders to a diagnostic tool.

Authors:  M Hupp; K Vallotton; C Brockmann; S Huwyler; J Rosner; R Sutter; M Klarhoefer; P Freund; M Farshad; A Curt
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

Review 8.  Bone in heart failure.

Authors:  Goran Loncar; Natasa Cvetinovic; Mitja Lainscak; Andjelka Isaković; Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-22       Impact factor: 12.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.